Dhande Pathlab Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.30 Cr
as on 13-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 2.95%
(FY 2023)
- Profit -0.06%
(FY 2023)
- Ebitda -2.76%
(FY 2023)
- Net Worth 25.01%
(FY 2023)
- Total Assets 23.81%
(FY 2023)
About Dhande Pathlab Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitin Dhande, Ashish Dhande, Manasi Dhande, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2014PTC151257
- Company No.
151257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dhande Pathlab Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Dhande  | Managing Director | 01-Apr-2014 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Dhande | Director | 01-Aug-2017 | Current |
| Manasi Dhande | Director | 01-Apr-2014 | Current |
| Ravindra Gupte | Director | 05-Oct-2015 | Current |
Financial Performance of Dhande Pathlab Diagnostics.
Dhande Pathlab Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.95% increase. The company also saw a slight decrease in profitability, with a 0.06% decrease in profit. The company's net worth Soared by an impressive increase of 25.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhande Pathlab Diagnostics?
Unlock access to Dhande Pathlab Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shri Dashabhuja Health Services Private LimitedActive 11 years 22 daysNitin Dhande is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dhande Pathlab Diagnostics?
Dhande Pathlab Diagnostics has a workforce of 109 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhande Pathlab Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhande Pathlab Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
